Polyvalent Vaccine-KLH Conjugate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Polyvalent Vaccine-KLH Conjugate, covering 2018-05-14 to 2018-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab [NA]